numient
amneal pharma europe ltd - l-dopa, карбидопа - parkinsonova bolest - antiparkinsonski lijekovi - simptomatsko liječenje bolesnika s parkinsonovom bolešću.
rivastigmine 1 a pharma
1 a pharma gmbh - rivastigmin - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - simptomatsko liječenje blage do umjereno teške alzheimerove demencije. simptomatsko liječenje blage do umjereno teške demencije kod pacijenata sa idiopatskom parkinsonovom bolešću.
monopril 20 mg/1 tableta tableta
amicus pharma d.o.o. - Фозиноприл - tableta - 20 mg/1 tableta - 1 tableta sadrži: 20 mg fosinoprilnatrija
monopril 10 mg/1 tableta tableta
amicus pharma d.o.o. - Фозиноприл - tableta - 10 mg/1 tableta - 1 tableta sadrži: 10 mg fosinoprilnatrija
daivobet 50 mikrograma/g + 0,5 mg/g gel
leo pharma a/s, industriparken 55, ballerup, danska - kalcipotriol hidrat betametazondipropionat - gel - 50 mikrograma/g + 0,5 mg/g - urbroj: jedan gram gela sadrži 50 mikrograma kalcipotriola (kao hidrat) i 0,5 mg betametazona (kao dipropionat)
enstilar 50 mikrograma/g + 0,5 mg/g pjena za kožu
leo pharma a/s, industriparken 55, ballerup, danska - kalcipotriol hidrat betametazondipropionat - pjena za kožu - 50 mikrograma/0,5 mg/g - urbroj: jedan gram pjene za kožu sadrži 50 mikrograma kalcipotriola (kao hidrat) i 0,5 mg betametazona (kao dipropionat)
ionsys
incline therapeutics europe ltd - fentanil hidroklorid - bol, postoperativna - analgetici - ionsys je indiciran za liječenje akutne umjerene do teške postoperativne boli u odraslih bolesnika.
medi-mibi 500 mikrograma set za pripravu radiofarmaceutika
radiopharmacy laboratory ltd., gyar utca 2, budaors, mađarska - metoksi-izobutil-izonitril bakrov(i) tetrafluoroborat - set za pripravu radiofarmaceutika - 500 mikrograma - urbroj: jedna bočica sadrži 500 mikrograma metoksi-izobutil-izonitril-bakrovog(i)-tetrafluoroborata
bimzelx
ucb pharma s.a. - bimekizumab - psorijaza - imunosupresivi - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastična sredstva - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.